AARD

Aardvark Therapeutics INC

-$102.1M

Net Activity

Institutions Holding

80

Popularity Rank

#4957

Avg Weight

0.03%

Total Value

$38.7M

Ownership Trend

80 institutions currently hold AARD, with 47 net buyers and 41 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

41

Net Buying Institutions

47

Key Holders

View all 80 holding institutions

Quarterly Activity

Recent Activity

+$19.2M

Total Buy Value

$30.8M

Total Sell Value

New buy29
Trim23
Add18
Sold out18

47

Net Buyers

41

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AARDVARK THERAPEUTICS INC (AARD)?
Major stakeholders currently include Decheng Capital LLC ($14.8M), Citadel Advisors LLC ($4.9M), Laurion Capital Management LP ($3.9M). Based on the latest 13F filings, there are a total of 80 tracked investment funds and institutions maintaining positions in AARD.
What is the overall institutional sentiment toward AARD recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $102.1M, driven by 47 managers accumulating shares while 41 reduced their exposure.
Which institutions have been selling or reducing their AARD positions?
In the latest period, 23 funds trimmed their holdings, and 18 managers completely exited their positions. The aggregate reported sell value was $30.8M.
Are there any notable investors adding AARD to their portfolios?
Yes, buying activity remains notable. 29 institutions opened new positions in {ticker}, and 18 existing holders added to their shares. The total reported buy value for the quarter amounted to $19.2M.

Related Stocks